PDCD1LG2 and neoplasm: Interaction between the PD-1 receptor on cytotoxic T cells and its ligands PD-L1 and PD-L2 on tumor cells is a mechanism by which neoplastic cells can dampen the tumor-specific immune response and evade anti-tumor immunity [13].